Yarrow Bioscience, Inc. (YARW)

NASDAQ: YARW · Real-Time Price · USD

25.54

-0.53 (-2.03%)

Sep 25, 2026, 4:00 PM EDT - Market closed

Yarrow Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Selling, General & Admin	1.56
Research & Development	2.42
Operating Expenses	3.98
Operating Income	-3.98
EBT Excluding Unusual Items	-3.98
Pretax Income	-283.98
Net Income	-283.98
Net Income to Common	-283.98
Net Income Growth	-
Shares Outstanding (Basic)	4
Shares Outstanding (Diluted)	4
Shares Change	-
EPS (Basic)	-66.82
EPS (Diluted)	-66.82
EPS Growth	-

Additional Metrics

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
EBIT	-3.98

SEC Filings: 10-K · 10-Q